AltPep
BiotechnologyView the employees at
AltPep-
Priscilla Long Research Associate at AltPep
-
Seattle, Washington, United States
-
Rising Star
Chen Katz Principal Scientist | Ph.D.-
United States
-
Rising Star
Milo Ryan Research Associate at AltPep-
Rising Star
Albert Choi Manager Business Operations @ AltPep | MBA, Strategy-
Seattle, Washington, United States
-
Top 10%
Julia Loghinov Computational Neuroscience Student and Undergraduate Researcher @ Carnegie Mellon University-
Rising Star
Overview
AltPep develops early disease-modifying treatments and detection tools for amyloid diseases by targeting one of the earliest molecular triggers – toxic soluble oligomers. These oligomers are associated with many diseases, including neurodegenerative diseases and type 2 diabetes. Decades of scientific research by the Daggett Research Group culminated in the discovery of a novel protein structure, alpha-sheet, the foundation of our innovative approach. Our lead program aims to identify Alzheimer’s Disease long before symptoms occur and then neutralize the toxic soluble oligomers associated with the disease.
-